• Kappa and Lambda Free Light Chains, Quantitative, Urine
  • Aspergillus fumigatus, IgE
  • TACSTD2 Gene Mutation Analysis
  • 1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), Bronchial Wash
  • Bismuth, Blood
  • Fragile X, FMR1 Gene Mutation Analysis
  • Cytochrome P450 2C9 (CYP2C9) Genotyping
  • Mycoplasma pneumoniae Antibody, IgA
  • Human Chorionic Gonadotropin (hCG), Quantitative, Serum
  • CD8 Lymphocyte Count
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
Medical Test

Methodology
Access to Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq) is restricted.
Loading...